Joeri Billast

𝐓𝐡𝐞 𝐖𝐞𝐛𝟑 𝐂𝐌𝐎 | 🚀 Leading B2B Metaverse & AI Marketing Innovations | 🎧 Host of Top 5% Global Podcast on Web3 | 🎤 Keynote Speaker | ✍️Bestselling Author

You have the technology. The ambition. Maybe even momentum.
But when marketing collides with AI, complexity, and trust, visibility stops being a channel problem and becomes a leadership problem.
That’s where I come in.

My name is Joeri Billast. I work as a Fractional CMO and AI Visibility strategist, helping brands grow when traditional marketing playbooks no longer deliver clarity or impact.

I support leadership teams with:
🧭 Fractional CMO leadership: positioning, priorities, and strategic focus
🤖 AI-driven marketing and visibility systems that compound trust and demand
✍️ Content and narrative frameworks that turn expertise into growth

Alongside my advisory work, I host Web3 CMO Stories, a top 5% global podcast focused on Web3, AI, and strategic brand building. The show brings sharp conversations for founders, CMOs, and senior marketers navigating visibility, trust, and narrative in fast-changing tech environments.

I’m also the author of The Future CMO, described by Philip Kotler as: 
“The best update I’ve read on the role of CMOs. A must-read.” 

And I regularly deliver keynotes based on The Future CMO for leadership teams and conferences exploring how AI, trust, and marketing leadership converge in practice.

You might want to reach out if:
🔹 marketing feels harder despite better tools
🔹 visibility is fragmented across platforms and AI systems
🔹 leadership needs clarity, not more tactics

DM me if this resonates.

Fractional CMO (chief marketing officer)

♈️ For tech scale-ups who don't want to hire a full-time marketing director 
♈️ I help them as a part-time CMO during a couple of days per week or per month

Zenza Capital

Director of Business Development

SymBio Pharmaceuticals Limited

Based on financial modelling/NPV analyses, initiated and participated in licensing discussions; worked closely with our CEO and board members to successfully in-license drug candidates for clinical development in Japan. Involved in drafting/editing of Indication of Interest/term sheets/license agreements, pharmacovigilance agreements, quality agreements, supply agreements, CDAs, CRO/CMO contracts, IP/patents, regulatory documents (for INDs/NDAs).

taplio

The Battle

Joeri Billast

David Thompson

Followers

Posts

Engagements

Likes

Ready to grow your LinkedIn presence?